Volume 15, Issue 6 (Special issue (Nov-Dec) 2021)                   mljgoums 2021, 15(6): 31-37 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bagherian F, Nikoonejad A, Allami A, Dodangeh S, Yassen L T, Hosienbeigi B. Investigation of Antibiotic Resistance Pattern in Isolated From Urine and Blood Samples of Patients Admitted To the Intensive Care Unit of Velayat Hospital in Qazvin, Iran. mljgoums 2021; 15 (6) :31-37
URL: http://mlj.goums.ac.ir/article-1-1368-en.html
1- Department of Infectious Diseases, Clinical Research Development Unit, BouAli Sina Hospital, Qazvin University of Medical of Sciences, Qazvin, Iran
2- Department of Infectious Diseases, Clinical Research Development Unit, Booalisina Hospital, Qazvin University of Medical of Sciences, Qazvin, Iran , nikoonejad.anikoo@gmail.com
3- Department of Infectious Diseases, Clinical Research Development Unit, Booalisina Hospital, Qazvin University of Medical of Sciences, Qazvin, Iran
4- Department of Medical Parasitology and Mycology, Children Growth Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran
5- Department of Medical Laboratory Techniques, Osoul Aldeen University College, Baghdad, Iraq
6- Department of Medical Parasitology and Mycology, Qazvin, Iran
Full-Text [PDF 740 kb]   (479 Downloads)     |   Abstract (HTML)  (3523 Views)
Full-Text:   (1270 Views)
INTRODUCTION
Bloodstream and urinary tract infections (UTIs) are the leading causes of death worldwide, especially in developing countries. Urinary tract infections can affect any part of the urinary tract including bladder, urethra, prostate or even kidneys (1). Numerous studies have shown that the most common bacterial cause of UTI are gram-negative bacteria such as Escherichia coli, Proteus, Klebsiella, Enterobacter as well as gram-positive bacteria such as Enterococcus and Staphylococcus saprophyticus. E. coli is the most common bacteria to cause UTI (2).
Septicemia or bloodstream infection (BSI) is a major cause of death in patients admitted to hospitals. It is also a leading cause of death in the U.S female population (3). Gram-negative bacteria are more likely to cause septicemia than gram-positive bacteria. The most common bacteria isolated from blood culture of septic patients are Acinetobacter, Klebsiella, Pseudomonas, E. coli, Enterobacter, Enterococcus, coagulase-negative staphylococci and Staphylococcus aureus (4).
The prevalence of UTI and BSI is high among hospitalized patients, especially those admitted to the intensive care unit (ICU). This may be due to the severity of underlying problems, decreased mobility and increased use of invasive devices (5). Although ICU beds make up approximately 5% of the total number of beds in each hospital, the rate of hospital-acquired infections in this ward is 5-10 times higher than other wards (6).
Infection with resistant strains in the ICU leads to increased risk of mortality and cost of care. The pattern of antibiotic resistance among pathogens isolated from ICU patients varies widely. In addition, certain types of pathogens that are common in a community can be considered as important risk factors for severe morbidity and mortality in ICU patients (7).
Investigating the pattern of antibiotic susceptibility in microorganisms isolated from ICU patients can help develop an appropriate antibiotic policy. It also prevents the unnecessary use of broad-spectrum antibiotics and the subsequent emergence of drug-resistant strains (8). This study was performed to determine the pattern of antibiotic resistance among bacteria causing UTI and BSI in patients admitted to the ICU of a hospital in Qazvin, Iran.  We believe that the results of this study can provide comprehensive information for physicians and hospital managers to reduce patient mortality and length of hospitalization by prescribing appropriate antibiotics.
 
MATERIALS AND METHODS
A retrospective cross-sectional study was performed using medical records of 1318 patients admitted to the ICU of Velayat Hospital in Qazvin (Iran) during 2017-2019. The study was approved by the ethics committee of Qazvin University of Medical Sciences (ethical code: IR.QUMS.REC.1399.248). All patients with a positive blood or urine culture who had history of hospitalization in the last month or less than five days have passed since their hospitalization were excluded from the study. Data including gender, culture samples, type of bacteria and the antibiotic susceptibility/resistance pattern were recorded for each patient.
Statistical analysis of data was carried out using SPSS software (version 25). Quantitative variables with normal distribution were described using mean and standard deviation (SD). Non-normal distributed data were described using mean and range. Number and percentage were used to describe the qualitative variables.
 
RESULTS
Among 1318 samples, 56.9% were taken from women and 43.1% were taken from men. In addition, 860 patients (65.3%) had positive urine culture, while 458 patients (34.7%) had positive blood culture. Positive urine culture was more frequent in women (64.25%) than in men (35.8%). Moreover, 56.8% of positive blood culture samples were taken from men. The most common bacteria isolated from urine and blood cultures were E. coli (68.6%) and Stenotrophomonas (41.0%), respectively. Figure 1 shows the frequency of bacteria isolates from urine and blood cultures of ICU patients.







The rate of antibiotic resistance was higher among Acinetobacter, E. coli, Stenotrophomonas, Enterococcus and Pseudomonas isolates. The most effective antibiotics against E. coli were meropenem (96.2%), imipenem (96.2%) and nitrofurantoin (85.7%). However, E. coli isolates were fully resistant against erythromycin, cefoxytin and penicillin. In case of Stenotrophomonas isolates, the highest susceptibility was observed to chloramphenicol (100%), levofloxacin (97.7%) and doxycycline (93.3%). However, this bacterium showed high resistance to a wide range of antibiotics including gentamicin, ampicillin, ceftriaxone, ceftazidime, nitrofurantoin, imipenem, cefepime, cefotaxime, piperacillin and amikacin (Table 1).
 
Table 1. Antibiotic resistance pattern among bacteria isolated from urine and blood samples of ICU patients
Antibiotic
 
Isolates
Number of resistant isolates (%)
MEM AK CIP CTX PRL FEP LEV CT C DA E CN OX FOX P AM PIP+TAZ CRO CAZ DO VA F IPM TE
Klebsiella
n=92
13 (26.5) 18 (24.7) 20 (43.5) 40 (54.8) 12 (60) 26 (48.1) 0 13 (54.2) 0 0 0 9 (37.5) 0 0 0 0 3 (75) 12 (70.6) 6 (85.7) 1 (20) 0 17 (47.2) 14 (21.1) 0
Escherichia
n=645
12 (3.8) 48 (10.6) 220 (58) 316 (70.1) 60 (82.2) 113 (45.2) 3 (60) 130 (65) 0 0 1 (100) 57 (26.3) 0 1 (100) 1 (100) 0 1 (16.7) 94 (46.1) 67 (55.4) 3 (37.5) 0 31 (10.5) 5 (3.8) 0
Stenotrophomonas
n=192
77 (93.9) 167 (90.8) 5 (20) 150 (98.7) 95 (96) 109 (99.1) 3 (2.3) 36 (22.9) 0 0 0 1 (100) 0 0 0 1 (100) 3 (50) 4 (100) 7 (100) 2 (6.7) 0 1 (100) 23 (100) 0
S. aureus
n=50
0 0 9 (50) 1 (50) 1 (100) 0 0 3 (30) 8 (19.5) 19 (42.2) 17 (43.6) 5 (17.9) 5 (26.3) 9 (33.3) 29 (78.4) 0 0 0 1 (100) 0 0 0 0 1 (20)
S.saprophyticus
n=12
0 0 3 (75) 0 0 0 0 1 (50) 3 (42.9) 6 (50) 9 (90) 2 (40) 1 (33.3) 6 (66.7) 6 (54.4) 0 0 0 0 0 0 0 0 0
S. epidermidis
n=80
0 0 17 (54.8) 0 0 0 0 7 (70) 12 (18.5) 40 (51.9) 52 (75.4) 25 (55.6) 25 (65.8) 18 (51.4) 57 (81.4) 1 (100) 0 1 (50) 0 0 0 0 0 7 (63.6)
Pseudomonas
n=94
43 (64.2) 52 (57.1) 10 (30.3) 10 (90.9) 63 (74.1) 58 (72.5) 0 2 (66.7) 0 0 0 0 0 0 0 0 41 (50) 0 7 (53.8) 1 (100) 0 3 (100) 11 (47.8) 0
Enterococcus
n=72
0 3 (100) 27 (90) 0 0 0 0 0 0 0 0   0 0 21 (77.8) 36 (53.7) 0 0 0 0 52 (72.2) 10 (24.4) 0 24 (82.8)
Proteus
n=7
2 (28.6) 2 (28.6) 2 (40) 6 (85.7) 2 (100) 2 (50) 0 0 0 0 0 0 0 0 0 0 0 1 (100) 1 (100) 0 0 2 (100) 0 0
Streptococcus
n=22
0 0 4 (33.3) 0 0 0 0 0 0 0 0 0 0 0 2 (18.2) 15 0 0 0 0 5 (22.7) 2 (18.2) 0 5 (71.4)
Enterobacter
n=24
2 (18.2) 3 (16.7) 8 (57.1) 13 (61.9) 4 (80) 6 (37.5) 0 7 (63.6) 0 0 0 4 (50) 0 0 0 0 0 6 (85.7) 4 (80) 1 (50) 0 8 (50) 1 (16.7) 0
Acinetobacter
n=28
20 (92.6) 25 (92.6) 7 (70) 25 (96.2) 16 (100) 22 (95.7) 3 (100) 5 (100) 0 0 0 0 0 0 0 0 2 (100) 0 4 (100) 5 (27.8) 0 2 (100) 3 (75) 0
Meropenem: MEM, Amikacin: AK, Ciprofloxacin: CIP, Cefotaxime: CTX, Piperacillin: PRL, Cefepime: FEP, Levofloxacin: LEV, Cotrimoxazole: CT, Chloramphenicol: C, Clindamycin: DA, Erythromycin: E, Gentamicin: CN, Oxacillin: OX, Cefoxitin: FOX, Penicillin: P, Ampicillin: AM, Piperacillin and Tazobactam: PIP+TAZ, Ceftriaxone: CRO, Ceftazidime: CAZ, Doxycycline: DO, Vancomycin: VA, Nitrofurantoin: F, Imipenem: IPM, Tetracycline: TE, Staphylococcus: S.
 
DISCUSSION
Urinary tract infection is an important public health problem worldwide that affect 150 million people each year (9). In our study, UTI was more common than BSI among ICU patients, which is in line with findings of a study by Ghafouri et al. in Bojnourd, Iran (10).
The frequency of UTI was higher among women, which can be due to the shortness of the urethra in women and the proximity of the urethra to the vagina and anus (11). In line with our findings, Fahimi Hamidi et al. (12) reported that the rate of UTI was higher in women.
In the present study, E. coli (68.6%) followed by Klebsiella and Enterococcus were the most common bacterial isolates from urine and blood cultures of ICU patients. Overall, E. coli has been known as the most frequent cause of UTI around the world, which could be due to the presence of this bacterium in the intestines and the risk of urethra contamination by fecal E. coli (13, 14). E. coli has been also reported as one of the leading causes of BSIs in various countries such as New Zealand, Sweden, Canada, Iceland, Australia, Denmark, Finland and the USA (15). However, the prevalence of BSIs caused by E. coli has decreased recently in hospitals of Brazil (16). This difference can be related to the hospital type, age of patients and geographical location.
In the present study, Stenotrophomonas (41%), followed by Pseudomonas and S. epidermidis were the most frequent causes of BSIs. Stenotrophomonas is a non-fermenting gram-negative bacillus that was previously classified as Pseudomonas and Xanthomonas (17, 18). This may justify the lower frequency of Stenotrophomonas in previous studies (19). However, a study by Jamali et al. (2011) in Tehran reported Stenotrophomonas as the most common bacterium isolated from blood culture (20). One of the reasons for the increasing prevalence of nosocomial infections caused by Stenotrophomonas may be due to the increasing number of patients with immunodeficiency, underlying diseases and cancer as well as transplant recipients who are significantly more susceptible to opportunistic infections (21). On the other hand, Stenotrophomonas is an environmental opportunistic pathogen that can be isolated from different hospital wards (22). Nevertheless, the high prevalence of this bacterium in our hospital may be due to contamination during the sampling process or the experiment procedure.
The results of the present study confirm the increased rate of antibiotic resistance among patients admitted to the ICU of Velayat hospital, especially in Acinetobacter, Stenotrofomonas and Pseudomonas isolates. The prevalence of resistance to carbapenems in isolates from ICUs in Qazvin was 26.6% in 2005, while in the present study, this rate increased to 95.2% (23).
The highest rate of resistance among E. coli isolates was observed against erythromycin, cefoxitin, penicillin and piperacillin. Whereas, resistance rates of less than 10% were recorded against imipenem, meropenem and nitrofurantoin. Similarly, two previous studies found no case of imipenem resistance among E. coli isolates (24, 25). Given these results, it is recommended to use carbapenem as the antibiotic of choice for the initial treatment of UTI caused by resistant E. coli.
In our study, Stenotrophomonas isolates were most sensitive to chloramphenicol, levofloxacin and doxycycline, followed by ciprofloxacin and cotrimaxazole. However, Stenotrophomonas isolates were highly resistant to a wide range of antibiotics including gentamicin, ampicillin, ceftriaxone, ceftazidime, nitrofurantoin, imipenem, cefepime, cefotaxime, piperacillin, meropenem and amikacin. In line with our findings, Nikpour et al. reported a sensitivity rate of 78% to levofloxacin among Stenotrophomonas isolates (22). In another study in Tehran, Stenotrophomonas was most sensitive to cotrimaxazole (19). However, Mohammadimehr et al. reported imipenem as the most effective antibiotic for treatment of infections caused by Stenotrophomonas species, which is inconsistent with our findings (26). The difference in the antibiotic resistance rates can be attributed to the differences in study location, tested samples, the prevalence of microorganisms and antibiotic therapies.
It has been demonstrated that the proper administration of antibiotics is the most important factor in preventing drug resistance. About 50% of antibiotic administrations are inappropriate, which not only increases treatment costs but also increases antibiotic resistance (27). In addition, long-term use of antibiotics is another important factor that contributes to the development of antibiotic resistance (28). We believe that the widespread use of immunosuppressive drugs in the Velayat hospital, particularly in the hematology and rheumatology wards, as well as the administration of broad-spectrum antibiotics, has led to the increased rate of antibiotic resistance. Nevertheless, transmissible resistance among pathogens has intensified the incidence of resistant hospital-acquired infection (29, 30).
 
CONCLUSION
Based on the results, the prevalence of antibiotic resistance is high among isolates from urine and blood samples of ICU patients in the Velayat hospital. Therefore, it is necessary to pay more attention to antibiotic prescription against these microorganisms, especially E. coli and Stenotrophomonas.
 
ACKNOWLEDGMENTS
The authors would like to thank the laboratory staff of the Velayat hospital for their cooperation.
 
DECLARATIONS
Funding
 This study was financially supported by the Qazvin University of Medical Sciences, Iran.
 
Ethics approvals and consent to participate
The study was approved by the ethics committee of Qazvin University of Medical Sciences (ethical code: IR.QUMS.REC.1399.248).
 
Conflict of interest
The authors declare that there is no conflict of interest regarding publication of this article
 



 
Research Article: Research Article | Subject: Microbiology
Received: 2021/02/23 | Accepted: 2021/06/21 | Published: 2021/10/18 | ePublished: 2021/10/18

References
1. Dielubanza EJ, Schaeffer AJ. Urinary tract infections in women. Med Clin North AM. 2011; 95(1): 27-41. [View at Publisher] [DOI:10.1016/j.mcna.2010.08.023] [PubMed] [Google Scholar]
2. Najari HR, Ghadimi A, Allami A. Relationship of ABO-Rh blood groups with urinary tract infections in hospitalized patients. Scientific Journal of Kurdistan University of Medical Sciences. 2020; 25(4): 20-30. [View at Publisher] [Google Scholar]
3. Heron MP. Deaths: leading causes for 2017. National Vital Statistics Reports. 2019: 68(6): 9. [View at Publisher] [PubMed] [Google Scholar]
4. Chun K, Syndergaard C, Damas C, Trubey R, Mukindaraj A, Qian S, et al. Sepsis Pathogen Identification. J Lab Autom. 2015; 20(5): 539-61. [View at Publisher] [DOI:10.1177/2211068214567345] [PubMed] [Google Scholar]
5. Emmerson AM. The epidemiology of infections in intensive care units. Intensive Care Med. 1990; 16 Suppl 3:S197-200. [View at Publisher] [DOI:10.1007/BF01709700] [PubMed] [Google Scholar]
6. Ddgari F, Ahmadi K, Mardani M, Ramezan Khani A. Frequency and antibiotic resistance profile of bacteria isolated from the intensive care unit and General ward at a general hospital in Tehran. Ann Military Health Sci Res. 2006; 5(1): 155-64. [Google Scholar]
7. Shehabi AA, Baadran I. Microbial infection and antbiotic resistance patterns among Jordanian intensivecare patients. Eastern Mediterranean Health Journal. 1996; 2: 515-520. [View at Publisher] [DOI:10.26719/1996.2.3.515] [Google Scholar]
8. Tullu MS, Deshmukh CT, Baveja SM. Bacterial profile and antimicrobial susceptibility pattern in catheter related nosocomial infections. J Post graduate Med. 1998; 44: 7-13. [View at Publisher] [PubMed] [Google Scholar]
9. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis. 2001; 183 (Suppl 1): S1–S4. [View at Publisher] [DOI] [PubMed] [Google Scholar]
10. Ghafouri M, Hashemi S, Azimian A, Garevani T, Seyed Sharifi S.H. Evaluation of Antibiotic Resistance to Bacteria Isolated from Patients with Nosocomial Infections Hospitalized in Imam Reza in Bojnurd City in 2013. JRUMS. 2015; 14(7): 599-610. http://journal.rums.ac.ir/article-1-2675-en.html [View at Publisher] [Google Scholar]
11. Mohammadi S, Ramazanzade R, Zandi S, Rouhi S, Mohammadi B. Determination of Prevalence of isolated bacteria from urinary tracts and antibiotic resistant pattern of them in Tohid hospital of Sanandaj (2013-2014). Zanko Journal of Medical Sciences. 2015; 16 (50): 55-62. (Persian) [View at Publisher] [Google Scholar]
12. Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol 2018; 219: 40–51. https://doi.org/10.1016/j.ajog.2017.12.231 [View at Publisher] [DOI] [PubMed] [Google Scholar]
13. Vranic SM, Zatric N, Rebic V, Aljicevic M, Abdulzaimovic A. The Most Frequent Isolates from Outpatients with Urinary Tract Infection. Mater Sociomed. 2017; 29 (1): 17-20. [DOI:10.5455/msm.2017.29.17-20] [PubMed] [Google Scholar]
14. Christofi T, Panayidou S, Dieronitou I, Michael C, Apidianakis Y. Metabolic output defines Escherichia coli as a health-promoting microbe against intestinal Pseudomonas aeruginosa. Scientific reports. 2019; 9(1):1-3. [View at Publisher] [DOI] [PubMed]
15. Laupland, K. B. Incidence of bloodstream infection: a review of population-based studies. Clin. Microbiol. Infect. 2013; 19, 492-500. [View at Publisher] [DOI:10.1111/1469-0691.12144] [PubMed] [Google Scholar]
16. Viana Taveira MR, Lima LS, de Araújo CC, de Mello MJ. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study. Pediatric blood & cancer. 2017 Feb;64(2):336-42. [View at Publisher] [DOI:10.1002/pbc.26225] [PubMed] [Google Scholar]
17. Bijari B, Abbasi A, Hemati M,et al. Nosocomial infections and related factors in southern khorasan hospitals. Iran J Microbiol. 2015; 8(4): 69-73. [View at Publisher] [Google Scholar]
18. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology E-Book: Elsevier Health Sciences. 2020. [Google Scholar]
19. Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clinical microbiology reviews. 2012; 25(1): 2-41. [View at Publisher] [DOI:10.1128/CMR.00019-11] [PubMed] [Google Scholar]
20. Jamali F, Boroumand MA, Yazdani F, et al. Minimal inhibitory concentration of ceftazidime and Co-trimoxazole for Stenotrophomonas maltophilia using E-test. J Glob Infect Dis. 2011; 3(3): 254. [View at Publisher] [DOI:10.4103/0974-777X.83531] [PubMed] [Google Scholar]
21. Guyot A, Turton JF, Garner D. Outbreak of Stenotroph-omonas maltophilia on an intensive care unit. J Hosp Infect. 2013; 85(4):303-7. [View at Publisher] [DOI:10.1016/j.jhin.2013.09.007] [PubMed] [Google Scholar]
22. Nikpour A, Shabani M, Kazemi A, Mohandesi M, Ershadpour R, Rezaei Yazdi H. Identification and Determination of Antibiotic Resistance Pattern of Stenotrophomonas maltophilia Isolated form Medical Devices and Clinical Samples in Jahrom, s Hospitals by Phenotype and Molecular Methods. Journal of Jahrom University of Medical Sciences. 2016; 14(2): 43-50. [View at Publisher] [DOI:10.29252/jmj.14.2.43] [Google Scholar]
23. Khosrishahi N, Sharifi M. Isolation of carbapenem resistant Acinetobacter baumannii (CRAB) strains from patients and equipments of Intensive care units (ICUs) at Qazvin between 2005-2006. Iran J Med Microbiol. 2007; 1 (3): 33-38. (Persian). [View at Publisher] [Google Scholar]
24. Khashei R, Navabi Z, Mohebi S, Samadi N. Antibiotic Resistance Among Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii Isolates Obtained From Shiraz Nemazi Hospital ICU Wards. Iran J Microbiol 2018; 12(4): 294-300. https://ijmm.ir/article-1-851-en.html [View at Publisher] [DOI:10.30699/ijmm.12.4.294] [Google Scholar]
25. Karami P, Bazmamoun H, Sedighi I, Mozaffari Nejad AS, Aslani MM, Alikhani MY. Antibacterial resistance patterns of extended spectrum β-lactamase-producing enteropathogenic Escherichia coli strains isolated from children. Arab J Gastroenterol. 2017; 18(4): 206-9. [View at Publisher] [DOI:10.1016/j.ajg.2017.11.004] [PubMed] [Google Scholar]
26. Mohammadi-mehr M, Feizabadi M. Antimicrobial resistance pattern of Gram-negative bacilli isolated from patients at ICUs of Army hospitals in Iran. Iran J Microbiol. 2011; 3(1): 26-30. [Persian] [Google Scholar]
27. Hooper DC. Bacterial Resistance to Antimicrobial Agents. Harrisons Principles of Internal Medicine. 2018; 1057-62. [View at Publisher]
28. Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clinical Microbiology and Infection. 2016 May 1;22(5):416-22. [View at Publisher] [DOI] [PubMed] [Google Scholar]
29. Askarian M, Gooran NR. National nosocomial infection surveillance system-based study in Iran: additional hospital stay attributable to nosocomial infections. Am J Infect Control. 2003; 31(8): 465-8. [View at Publisher] [DOI:10.1016/S0196-6553(03)00673-4] [PubMed] [Google Scholar]
30. Gastmeier P, Geffers C, Schwab F, et al. Development of a surveillance system for nosocomial infections: the component for neonatal intensive care units in Germany. J Hosp Infect. 2004; 57(2): 126-31. [View at Publisher] [DOI:10.1016/j.jhin.2003.12.038] [PubMed] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.